Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation. 2012;125:2138 50. CLINICAL STATEMENTS AND GUIDELINES 7.2.2.5. Diagnostic Testing: Exercise Testing 1. Tischler MD, Battle RW, Ashikaga T, et al. Effects of exercise on left ven- tricular performance determined by echocardiography in chronic, severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. 1996;77:397 402. 2. Tischler MD, Battle RW, Saha M, et al. Observations suggesting a high inci- dence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J Am Coll Cardiol. 1995;25:128 33. 3. Magne J, Lancellotti P, Pi rard LA. Exercise-induced changes in degenera- tive mitral regurgitation. J Am Coll Cardiol. 2010;56:300 9. 4. Magne J, Lancellotti P, Pi rard LA. Exercise pulmonary hypertension in as- ymptomatic degenerative mitral regurgitation. Circulation. 2010;122:33 41. 7.2.3. Medical Therapy 1. Ahmed MI, Aban I, Lloyd SG, et al. A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgita- tion. J Am Coll Cardiol. 2012;60:833 8. 2. Nemoto S, Hamawaki M, De Freitas G, et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adren- ergic receptor blocker atenolol on hemodynamics and left ventricular con- tractile function in experimental mitral regurgitation. J Am Coll Cardiol. 2002;40:149 54. 3. Varadarajan P, Joshi N, Appel D, et al. Effect of beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ven- tricular ejection fraction. Am J Cardiol. 2008;102:611 5. 4. Dujardin KS, Enriquez-Sarano M, Bailey KR, et al. Effect of losartan on de- gree of mitral regurgitation quantified by echocardiography. Am J Cardiol. 2001;87:570 6. 5. Harris KM, Aeppli DM, Carey CF. Effects of angiotensin-converting en- zyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity. Am Heart J. 2005;150:1106. 6. 